SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-003202
Filing Date
2020-01-13
Accepted
2020-01-13 17:13:39
Documents
1
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2386
  Complete submission text file 0001209191-20-003202.txt   4055
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 E COLORADO BLVD STE 700 PASADENA CA 91105
Business Address
Hassard James (Reporting) CIK: 0001799357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 20524341